Ottawa Hospital

Futó vizsgálatok

• Még nem toboroz

  SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive Therapy

  NCT07687160· 4. fázis· Forrás

• Még nem toboroz

  Mycophenolate After Stem Cell Transplant for Systemic Sclerosis

  NCT07734012· 2. fázis· Forrás

• Még nem toboroz

  Cardiac CT Angiography in Acute Stroke Imaging (SCOPE-CT)

  NCT07896889· Forrás

• Még nem toboroz

  Phase II Study of CAmizestrant in Resectable Endometrial Adenocarcinoma

  NCT07840443· 2. fázis· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Forrás

• Toboroz

  Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

  NCT06943573· 2. fázis· Forrás

• Toboroz

  The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

  NCT06494878· 3. fázis· Forrás

• Toboroz

  Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

  NCT07372716· Forrás

• Toboroz

  Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment

  NCT07304154· 1. fázis· Forrás

• Toboroz

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  NCT07361497· 3. fázis· Forrás

• Toboroz

  Canadian Consortium on Airway Mucus Occlusions in Asthma, COPD and Chronic Cough

  NCT06858748· Forrás

• Toboroz

  First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

  NCT07216066· 1. fázis· Forrás

• Toboroz

  Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

  NCT06983821· 3. fázis· Forrás

• Toboroz

  A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  NCT07175285· Forrás

• Toboroz

  A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  NCT06989437· 2/3. fázis· Forrás

• Toboroz

  A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

  NCT06926868· 2/3. fázis· Forrás

• Még nem toboroz

  Do Blood Tests Help to Decide Which Patients With Flares of Chronic Obstructive Pulmonary Disease (COPD) Need Antibiotics and Steroids?

  NCT06929767· 4. fázis· Forrás

• Toboroz

  A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

  NCT07112339· 4. fázis· Forrás

• Toboroz

  DIALysis With EXpanded Solute Removal

  NCT06660277· Forrás

• Toboroz

  A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  NCT07005102· 2/3. fázis· Forrás

• Toboroz

  Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study

  NCT07094529· Forrás

• Toboroz

  Feasibility Trial for a Right Ventricular Failure Platform Trial

  NCT06570473· 2. fázis· Forrás

• Meghívásos bevonás

  A Study of KITE-363 in Participants With Refractory Autoimmune Diseases

  NCT07038447· 1. fázis· Forrás

• Toboroz

  Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  NCT06937086· 3. fázis· Forrás

• Toboroz

  Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  NCT06937099· 3. fázis· Forrás

• Toboroz

  Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)

  NCT07002450· Forrás

• Toboroz

  A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

  NCT06943872· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease

  NCT06816810· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  NCT06782490· 2. fázis· Forrás

• Toboroz

  Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

  NCT06256575· Forrás

• Toboroz

  The Dragon PLC Trial (DRAGON-PLC)

  NCT06914648· Forrás

• Toboroz

  Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

  NCT06957366· Forrás

• Toboroz

  Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

  NCT06421675· 2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  NCT06618287· 1/2. fázis· Forrás

• Toboroz

  CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

  NCT06208735· 1. fázis· Forrás

• Fut, nem toboroz

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· 3. fázis· Forrás

• Fut, nem toboroz

  SpaceIT Hydrogel System for Perirectal Spacing

  NCT06451614· Forrás

• Toboroz

  A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

  NCT06662786· 3. fázis· Forrás

• Fut, nem toboroz

  A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

  NCT06447168· Forrás

• Toboroz

  Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

  NCT06561048· 3. fázis· Forrás

• Fut, nem toboroz

  MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

  NCT06586515· 1. fázis· Forrás

• Fut, nem toboroz

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· 3. fázis· Forrás

• Fut, nem toboroz

  A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

  NCT06413498· 3. fázis· Forrás

• Fut, nem toboroz

  A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

  NCT06384261· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

  NCT06483334· 1/2. fázis· Forrás

• Toboroz

  Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL

  NCT06392776· Forrás

• Toboroz

  Pancreatic Insulin Production Capacity (PIPC) - a Feasibility Study

  NCT06462170· Forrás

• Toboroz

  Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  NCT06393374· 3. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

  NCT06294925· Forrás

• Fut, nem toboroz

  VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

  NCT06249555· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Pitvarfibrilláció8 toboroz
• Tüdőrák7 toboroz
• Krónikus limfoid leukémia (CLL)5 toboroz
• Asztma4 toboroz
• Stroke (szélütés)4 toboroz
• 2-es típusú cukorbetegség3 toboroz
• Gyermekkori daganatok3 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)3 toboroz
• Máj- és epeúti rák3 toboroz
• Szarkóma3 toboroz
• Szisztémás szklerózis (szkleroderma)3 toboroz
• Tripla negatív emlőrák3 toboroz
• Vastagbélrák3 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Elhízás2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Hasnyálmirigyrák2 toboroz
• Huntington-kór2 toboroz
• Köpenysejtes limfóma2 toboroz
• Lupus (SLE)2 toboroz
• Magas vérnyomás2 toboroz
• Parkinson-kór2 toboroz
• Prosztatarák2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Áttétes emlőrák1 toboroz
• Bipoláris zavar1 toboroz
• Colitis ulcerosa1 toboroz
• Crohn-betegség1 toboroz
• Depresszió1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Hólyagrák1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus vesebetegség1 toboroz
• Méhtestrák1 toboroz
• Melanóma1 toboroz
• Mielóma multiplex1 toboroz
• Myasthenia gravis1 toboroz
• Neuroendokrin daganatok1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Szívelégtelenség1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer

  NCT05849129· 2. fázis· Forrás

• Visszavonták

  The UCAP 2 Pilot Study

  NCT06014840· Forrás

• Lezárult

  RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine

  NCT05513560· 2/3. fázis· Forrás

• Lezárult

  Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

  NCT05546476· 2. fázis· Forrás

• Lezárult

  Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma

  NCT05218499· 2/3. fázis· Forrás

• Lezárult

  A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

  NCT05064059· 3. fázis· Forrás

• Leállították

  MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

  NCT05090566· 2. fázis· Forrás

• Lezárult

  Study of WVE-003 in Patients With Huntington's Disease

  NCT05032196· 1/2. fázis· Forrás

• Lezárult

  RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

  NCT04485195· 4. fázis· Forrás

• Lezárult

  An Observational Study to Evaluate the Clinical Utility of the Oncomine Precision Assay Within the Exactis Network

  NCT04564079· Forrás

• Lezárult

  Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients

  NCT04243122· 2. fázis· Forrás

• Leállították

  HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)

  NCT04684914· 2. fázis· Forrás

• Lezárult

  A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1

  NCT03776071· 3. fázis· Forrás

• Lezárult

  A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

  NCT04266795· 2. fázis· Forrás

• Lezárult

  A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes

  NCT04560998· 3. fázis· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

  NCT04210115· 3. fázis· Forrás

• Lezárult

  A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

  NCT04209855· 3. fázis· Forrás

• Lezárult

  Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  NCT03781063· 2. fázis· Forrás

• Lezárult

  I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).

  NCT03939689· 2. fázis· Forrás

• Lezárult

  Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

  NCT03941093· 3. fázis· Forrás

• Lezárult

  A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)

  NCT03516981· 2. fázis· Forrás

• Lezárult

  PSMA-PET Registry for Recurrent Prostate Cancer

  NCT03718260· Forrás

• Lezárult

  This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)

  NCT03599245· 3. fázis· Forrás

• Leállították

  WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

  NCT03297359· 2. fázis· Forrás

• Lezárult

  Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

  NCT03391466· 3. fázis· Forrás

• Lezárult

  Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

  NCT03269994· 3. fázis· Forrás

• Lezárult

  A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma

  NCT03274492· 3. fázis· Forrás

• Lezárult

  A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

  NCT03332017· 2. fázis· Forrás

• Lezárult

  A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

  NCT03213457· 3. fázis· Forrás

• Lezárult

  Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis

  NCT03232073· 3. fázis· Forrás

• Lezárult

  Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)

  NCT03269110· Forrás

• Lezárult

  Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

  NCT03112174· 3. fázis· Forrás

• Lezárult

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· 3. fázis· Forrás

• Lezárult

  Undiagnosed COPD and Asthma Population Study (UCAP)

  NCT03148210· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

  NCT03040999· 3. fázis· Forrás

• Lezárult

  Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)

  NCT03036488· 3. fázis· Forrás

Vizsgálati helyszínek

• Department of Psychiatry, University of Ottawa, The Ottawa Hospital1 vizsgálat
• L'Hopital d'Ottawa1 vizsgálat
• Ottawa Hospital15 vizsgálat
• Ottawa Hospital - General Campus6 vizsgálat
• The Ottawa Hospital68 vizsgálat
• The Ottawa Hospital - Cancer Care (Site 0008)1 vizsgálat
• The Ottawa Hospital - Cancer Care (Site 0052)1 vizsgálat
• The Ottawa Hospital - Cancer Care (Site 0100)1 vizsgálat
• The Ottawa Hospital - Civic Campus6 vizsgálat
• The Ottawa Hospital - General Campus51 vizsgálat
• The Ottawa Hospital - General Campus /ID# 2633151 vizsgálat
• The Ottawa Hospital - General Campus /ID# 2644701 vizsgálat
• The Ottawa Hospital - General Campus /ID# 2693911 vizsgálat
• The Ottawa Hospital - General Campus /ID# 2756111 vizsgálat
• The Ottawa Hospital - General Campus (Site 0102)1 vizsgálat
• The Ottawa Hospital - General Campus (Site 0286)1 vizsgálat
• The Ottawa Hospital - General Campus (Site 0414)1 vizsgálat
• The Ottawa Hospital - General Campus (Site 4105)1 vizsgálat
• The Ottawa Hospital, IBD Centre of Excellence1 vizsgálat
• The Ottawa Hospital /ID# 1489271 vizsgálat
• The Ottawa Hospital_Riverside1 vizsgálat
• The Ottawa Hospital - Riverside Campus2 vizsgálat
• The Ottawa Hospital (Site 0058)1 vizsgálat
• The Ottawa Hospital (Site 0151)1 vizsgálat
• The Ottawa Hospital (Site 0306)1 vizsgálat
• The Ottawa Hospital (Site 0404)1 vizsgálat
• University of Ottawa; The Ottawa Hospital1 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Bipoláris zavar21 munka · 1 vizsgálat